MARITES MOLINA-MATRO: Open Payments
NPI 1699338756 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 42 payments from 11 companies in 2025. Trend: 2023 $772 · 2024 $1,048 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $193 |
| Otsuka America Pharmaceutical, Inc. | 6 | $191 |
| Travere Therapeutics, Inc. | 3 | $188 |
| Vifor Pharma, Inc. | 11 | $146 |
| Amgen Inc. | 5 | $142 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Apellis Pharmaceuticals, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Calliditas Therapeutics US Inc. | 1 | $30 |
Products named: JARDIANCE, Veltassa, KRYSTEXXA, Filspari, JYNARQUE, PURIFIED CORTROPHIN GEL, Empaveli, Fabhalta.
Industry payments across NV — which companies pay providers there.
